Macromolecule Crystallization Screening Results Analysis
Award amount
$149,999Program and phase
STTR · Phase IAward year
2015Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- iXpressGenes, Inc.
- Proposal award date
- 2015-08-15
- Contract end date
- 2016-09-14
- UEI
- TSJKJXX5GNN8
- Solicitation number
- PA14-072
- Topic code
- 100
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Producing Novel Biosynthetic Therapeutics from Extreme Microbiomes
- Macromolecule Crystallization Screening Results Analysis
- Producing Novel Biosynthetic Therapeutics from Extreme Microbiomes
- Fluorescence Intensity-based Scoring of Macromolecule Crystallization Plates
- Fluorescence Anisotropy-based Macromolecule Crystallization Screening
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- First-in-class TREM-1 inhibitors for neovascular retinal diseases
- Development of a Novel Biosensor to Accelerate Investigations of the Gut Microbiome
- Magnetic Lipid Nanoprobe Platform for Rapid, Highly-Efficient, and Cost-Effective Isolation of Extracellular Vesicles from Non-Invasive Bodily Fluids
- Scale-up and Manufacturing of STLR-201, an off-the-shelf regenerative therapeutic for Sjogren's syndrome-related dry eye disease
- Integrated assays of single-cell dynamics and molecular phenotype for cell therapy manufacturing
Research funding history
9 SBIR/STTR records share this UEI (2006–2017). Reported award amounts total $4,039,932. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Defense, National Science Foundation